Allogene Therapeutics, Inc.

ALLO

$0.9

Name : Allogene Therapeutics, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $311,855,200.00

EPSttm : -0.61

Allogene Therapeutics, Inc.

$0.9

3.41%

$0.032

ALLO — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

19.83

Margin Of Safety %

Put/Call OI Ratio

0.07

EPS Next Q Diff

0.01

EPS Last/This Y

0.29

EPS This/Next Y

-0.04

Price

0.9

Target Price

8.75

Analyst Recom

1.27

Performance Q

-54.54

Upside

-995.6%

Beta

0.81

Ticker: ALLO

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-13	ALLO	1.3	0.09	2.86	15800
2026-10-14	ALLO	1.295	0.11	0.74	16250
2026-10-15	ALLO	1.335	0.13	0.01	16846
2026-10-16	ALLO	1.305	0.12	0.00	16989
2026-10-19	ALLO	1.295	0.13	0.02	14554
2026-10-20	ALLO	1.325	0.13	0.00	14409
2026-10-21	ALLO	1.325	0.12	0.00	14848
2026-10-22	ALLO	1.25	0.12	0.00	14877
2026-10-23	ALLO	1.245	0.12	0.00	14935
2026-10-26	ALLO	1.22	0.12	0.00	15023
2026-10-27	ALLO	1.225	0.12	0.03	15301
2026-10-28	ALLO	1.305	0.12	0.00	15375
2026-10-29	ALLO	1.255	0.11	0.13	16408
2026-10-30	ALLO	1.175	0.11	0.00	16423
2026-11-02	ALLO	1.085	0.11	0.04	16345
2026-11-03	ALLO	1.125	0.11	0.12	16946
2026-11-04	ALLO	1.185	0.11	0.12	17016
2026-11-05	ALLO	1.08	0.11	0.10	16937
2026-11-06	ALLO	1.035	0.11	0.03	17043
2026-11-09	ALLO	1.075	0.07	0.16	17177
2026-11-10	ALLO	0.9319	0.07	0.32	17389
2026-11-11	ALLO	0.9038	0.07	0.07	17655
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-13	ALLO	1.29	25.9	-	-0.59
2026-10-14	ALLO	1.29	25.9	-	-0.59
2026-10-15	ALLO	1.33	25.9	-	-0.59
2026-10-16	ALLO	1.31	25.9	-	-0.59
2026-10-19	ALLO	1.30	25.9	-	-0.59
2026-10-20	ALLO	1.30	25.9	-	-0.59
2026-10-21	ALLO	1.33	25.9	-	-0.59
2026-10-22	ALLO	1.25	25.9	-	-0.59
2026-10-23	ALLO	1.24	25.9	-	-0.59
2026-10-26	ALLO	1.22	25.9	-	-0.58
2026-10-27	ALLO	1.23	25.9	-	-0.58
2026-10-28	ALLO	1.30	25.9	-	-0.58
2026-10-29	ALLO	1.25	25.9	-	-0.58
2026-10-30	ALLO	1.17	25.9	-	-0.58
2026-11-02	ALLO	1.08	25.9	-	-0.58
2026-11-03	ALLO	1.12	25.9	-	-0.58
2026-11-04	ALLO	1.18	25.9	-	-0.58
2026-11-05	ALLO	1.09	25.9	-	-0.58
2026-11-06	ALLO	1.03	25.9	-	-0.58
2026-11-09	ALLO	1.08	25.9	-	-0.58
2026-11-10	ALLO	0.93	25.9	-	-0.58
2026-11-11	ALLO	0.90	25.9	-	-0.58
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-13	ALLO	-0.04	40.69	21.57
2026-10-14	ALLO	-0.04	40.69	21.57
2026-10-15	ALLO	-0.04	40.69	21.57
2026-10-16	ALLO	-0.04	40.69	21.57
2026-10-19	ALLO	-0.04	40.45	21.57
2026-10-20	ALLO	-0.04	40.45	21.57
2026-10-21	ALLO	-0.04	40.45	21.57
2026-10-22	ALLO	-0.04	40.45	21.57
2026-10-23	ALLO	-0.04	40.45	21.57
2026-10-26	ALLO	-0.08	39.90	21.57
2026-10-27	ALLO	-0.08	39.90	20.71
2026-10-28	ALLO	-0.08	39.90	20.71
2026-10-29	ALLO	-0.08	39.90	20.71
2026-10-30	ALLO	-0.08	39.90	20.71
2026-11-02	ALLO	-0.08	29.68	20.71
2026-11-03	ALLO	-0.08	29.68	20.71
2026-11-05	ALLO	-0.08	29.68	20.71
2026-11-06	ALLO	-0.08	29.68	20.71
2026-11-09	ALLO	-0.08	26.90	20.71
2026-11-10	ALLO	-0.08	26.90	20.71
2026-11-11	ALLO	-0.08	26.90	19.83
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.15

Avg. EPS Est. Current Quarter

-0.14

Avg. EPS Est. Next Quarter

-0.14

Insider Transactions

-0.08

Institutional Transactions

26.9

Beta

0.81

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

95.4

Max Drawdown 5-Year %

-95.2

Target Price

8.75

P/E

Forward P/E

PEG

P/S

67.21

P/B

0.79

P/Free Cash Flow

EPS

-0.62

Average EPS Est. Cur. Y

-0.58

EPS Next Y. (Est.)

-0.62

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-3759.98

Relative Volume

2.17

Return on Equity vs Sector %

-70.8

Return on Equity vs Industry %

-51.3

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

◆ ALLO Healthcare

$0.90

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

11/25

Volume

3/15

Valuation

12/20

TP/AR

2/10

Options

7/10

RSI

24.6

Range 1M

3.1%

Sup Dist

3.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

18/25

Growth

14/30

Estimates

1/20

Inst/Vol

8/15

Options

10/10

EPS Yr

30.6%

EPS NY

-6.4%

52W%

0.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +872.2% upside

Quality

3/30

Valuation

16/30

Growth

9/25

Stability

8/10

LT Trend

4/5

Upside

+872.2%

Quality

ALLO — P/E HistoricalBiotechnology

Allogene Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 150

Allogene Therapeutics, Inc. a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer and autoimmune diseases. It develops a pipeline of multiple allogeneic CAR T cell product candidates utilizing protein engineering, gene editing, gene insertion, and advanced proprietary T cell manufacturing technologies. The company is also developing cemacabtagene ansegedleucel (cema-cel), an engineered allogeneic CAR T cell product candidate that targets CD19 for the treatment of large B-cell lymphoma (LBCL). In addition, it develops ALLO-316, an engineered allogeneic CAR T cell product candidate that targets CD70 to treat renal cell carcinoma (RCC); and ALLO-329, an engineered allogeneic CAR T cell product candidate that targets both CD19 and CD70 for the treatment of autoimmune diseases (AID), such as systemic lupus erythematosus (SLE), idiopathic inflammatory myopathies (IIM), and systemic sclerosis (SSc). The company was incorporated in 2017 and is headquartered in South San Francisco, California.

ALLO

Latest News

—

Caricamento notizie per ALLO…

stock quote shares ALLO – Allogene Therapeutics, Inc. Stock Price stock today

news today ALLO – Allogene Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ALLO – Allogene Therapeutics, Inc. yahoo finance google finance

stock history ALLO – Allogene Therapeutics, Inc. invest stock market

stock prices ALLO premarket after hours

ticker ALLO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ALLO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y